Indefinite Delivery Contract SPE2DV17D0306

The federal contract IDV award SPE2DV17D0306 is a single-award Indefinite Delivery Contract (IDC) held by Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract has a ceiling value of $4,999,999 and a period of performance through August 27, 2027, allowing the Defense Logistics Agency (DLA) to rapidly procure a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515. Cardinal Health 200, LLC has been awarded multiple delivery orders against this IDC, as well as other IDCs, to supply surgical dressings, drugs, biologicals, and other medical consumables to support military treatment facilities and Department of Defense customers in DLA Region 1. As a major supplier of medical and pharmaceutical products to the U.S. federal government, Cardinal Health leverages its extensive distribution network and expertise to deliver essential healthcare supplies efficiently and at scale to meet the ongoing needs of both military and civilian government agencies, including the Department of Veterans Affairs and National Institutes of Health.

Cardinal Health, Inc., the parent company of Cardinal Health 200, LLC, holds several significant federal contract IDVs, including a single-award IDC with the Department of Veterans Affairs for the provision of radiopharmaceutical products to support medical imaging procedures within the VA healthcare system. Additionally, the company's subsidiary, The Harvard Drug Group, L.L.C., secured a single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets, demonstrating Cardinal Health's ability to manage large-scale, multi-agency pharmaceutical supply agreements.